| abstract |
The present invention relates to an isolated and recombinant fusion peptabody that binds to a member of the epidermal growth factor receptor (EGFR), which is useful for inhibiting the proliferation of certain cancer cells. Also disclosed are nucleic acids encoding the isolated and recombinant fusion peptabody, kits and pharmaceutical compositions comprising the isolated and recombinant fusion peptabody as active ingredients. In addition, a method for preparing the isolated and recombinant fusion peptabody and its use for the manufacture of a drug for preventing or treating cancer are provided. |